Plant Material Or Plant Extract Of Undetermined Constitution As Active Ingredient (e.g., Herbal Remedy, Herbal Extract, Powder, Oil, Etc.) Patents (Class 424/725)
  • Patent number: 10688190
    Abstract: A method for delivering therapeutics includes infusing medication with cannabis.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: June 23, 2020
    Inventor: Shabana Naheed
  • Patent number: 10688158
    Abstract: The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and a milk thistle extract or powder. The invention also relates to the combination of a sulforaphane or a derivative thereof and a milk thistle extract or powder. The invention also relates to the combination of a broccoli extract or powder and a milk thistle extract or powder. The invention provides compositions and methods relating to these combinations.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: June 23, 2020
    Assignee: NUTRAMAX LABORATORIES, INC.
    Inventors: Brian Cornblatt, Grace Cornblatt, Anton Bzhelyansky, Robert Henderson
  • Patent number: 10688078
    Abstract: The invention relates to a use of a compound for manufacturing a medicament for treating an allergic disease, wherein the compound is selected from the group consisting of ovatodiolide, 1?-acetoxychavicol acetate, zerumbone and combination thereof. Also provided is a method and a composition for treating an allergic disease.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: June 23, 2020
    Assignee: ARJIL BIOTECH HOLDING COMPANY LIMITED
    Inventors: Yeh B Wu, Jir-Mehng Lo, Hui Ju Liang, Pei-Hsin Lin
  • Patent number: 10688128
    Abstract: A method for at least one of activating autoimmune system and treating cancer is provided. The method comprises administering to a subject in need an effective amount of Z-butylidenephthalide and an effective amount of mononuclear cells.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: June 23, 2020
    Assignee: EVERFRONT BIOTECH INC.
    Inventors: Hong-Lin Su, Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou, Sheng-Feng Tsai
  • Patent number: 10682366
    Abstract: The present invention relates to compositions for enhancing innate immunity, comprising ginsenoside F1 as an active ingredient. Specifically, the composition according to the present invention promotes degranulation activity and cell-killing activity of natural killer cells, and increases expressions of cell-killing factors, thereby being effectively used as an innate immunity enhancer.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: June 16, 2020
    Assignee: INTELLIGENT SYNTHETIC BIOLOGY CENTER
    Inventors: Sun Chang Kim, Hun Sik Kim
  • Patent number: 10684272
    Abstract: Presently disclosed is a method of modulating Hepatitis B virus (HBV) replication, by contacting the cell with at least one agent that modulates at least one factor from a specified group consisting of SNAI2, SOX7 and other factors, the screening of said agent and use thereof in a medicament for treating HBV infection or disease or condition associated with a HBV infection in a subject. In one preferred embodiment, the agent is one peptide derived from SOX7 or SNAI2 or stapled peptides thereof. As a separate invention, a method of identifying at least one factor that modulates replication of a virus is also disclosed.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: June 16, 2020
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Ee Chee Ren, Hul Ling Ko
  • Patent number: 10675252
    Abstract: Veterinary compositions and methods for production and use. A method of treating bees at or near a bee hive with a first and/or second veterinary composition is described including administering to bees a veterinary composition comprising at least cannabinoid, and/or at least two non-cannabinoid cannabis compounds, with or without a carrier, thereby enhancing bees performance.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: June 9, 2020
    Assignee: Canna-B Cure Ltd
    Inventors: Aharon M. Eyal, Netta Lin-Cohen, Youval Lin, Meir Ariel
  • Patent number: 10668120
    Abstract: A pharmaceutical or cosmetic composition is provided. The composition includes an Indigo Naturalis or Indigo-producing plant extract, for inhibiting Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. A method of inhibiting Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, is also provided. The method includes contacting a cell with an effective amount of an Indigo Naturalis or Indigo-producing plant extract.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: June 2, 2020
    Assignee: Galderma SA
    Inventors: Yin-Ku Lin, Philippe Andres, Laurent Chantalat
  • Patent number: 10668044
    Abstract: Blended, processed marijuana and/or hemp cannabis compounds and methods of making the same are provided. In particular, the compound includes one or more species of cannabis mixed in various ways with other ingredients in order to produce a new matter, food product, oil, or drink, in the form of gummies, creams, salves, tablets, capsules, pastes, gelatin suppositories, crystals, ointments, jellies, e-juices, powders, pills, syrups, drops, patches, chewing gums, dried whole or partial plant parts, and dusts, such that it is safe for mammals and provides assistance in dealing with various ailments and diseases.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: June 2, 2020
    Inventor: William H. Muscarella
  • Patent number: 10668121
    Abstract: Provided herein are compositions, methods of use thereof and kits comprising same for prophylaxis, alleviating or treating a subject with, or experiencing symptoms associated with, attention deficit disorder/attention deficit hyperactivity disorder (ADD/ADHD) and related disorders. Specifically, the compositions comprise a magnesium mineral, vitamin D and at least one botanical component, in amounts such that the supplement is effective for preventing, alleviating and/or treating a child, teen or adult subject with ADD/ADHD and related disorders or one or more symptoms associated with ADD/ADHD and related disorders.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: June 2, 2020
    Inventor: Yeheskel Tsion
  • Patent number: 10672514
    Abstract: The present disclosure relates to systems and methods for bioinformatics and data processing. In particular, in a first aspect, the present disclosure relates to methods and systems for generating a personalized treatment guideline for a patient and for selecting a treatment for a patient. In another aspect, the present disclosure relates to methods and systems for selecting patients for a clinical trial of a treatment. The invention resolves cases in which patients have more than one “actionable” aberration by combining the patient-specific molecular information and the treatment-specific molecular information further with a clinico-molecular disease model, specifically a scoring of genes and/or proteins that represents several aspects of their involvement into the disease. In this way, treatments and patients can be prioritized that are most likely to impact or impacted by the disease mechanism, respectively.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: June 2, 2020
    Assignee: Molecular Health GmbH
    Inventors: Alexander Zien, David B. Jackson, Martin Stein, Guillaume Taglang, Stephan Brock, Alexander Picker, Theodoros Soldatos, Bernhard Sulzer
  • Patent number: 10660864
    Abstract: A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide. A composition and method for the use of falcarinol for the attenuation of Cannabis-induced dysphoria and reverse cannabis tolerance where the dosage of at least 30 mg can be effectively administered for buccal absorption.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 26, 2020
    Assignee: ENGEN MEDICAL CORPORATION
    Inventors: Paul Epner, Richard Zimmer, III, Bill W. Massey
  • Patent number: 10660931
    Abstract: Herbo-mineral formulation for the treatment of cancer and method of preparation are disclosed herein. The disclosed formulation includes a combination of herb and mineral components that facilitate in controlling abnormal cell proliferation. The formulation can thus be used in treatment of cancer and related mobidities.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: May 26, 2020
    Assignee: MUNIYAL AYURVEDIC RESEARCH CENTRE
    Inventor: M Vijayabhanu Shetty
  • Patent number: 10660927
    Abstract: The present invention relates to a composition, containing extracts of Dipsacus asperoides(Phlomis umbrosa Turcz) and Cynanchum wilfordii as active ingredients, for promoting exercise ability and/or muscle formation. The intake of the composition according to the present invention promotes motor performance ability, and is useful in the promotion of muscle development.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: May 26, 2020
    Assignee: BRAINON INC.
    Inventor: Yongkoo Kang
  • Patent number: 10653736
    Abstract: A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of tetrahydrocannabinol, cannabidiol, or both in the topical formulation is greater than 2 milligrams per kilogram.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: May 19, 2020
    Inventors: Ronald D. Sekura, Roscoe M. Moore
  • Patent number: 10653640
    Abstract: Provided herein are cannabinoid-containing complex mixtures suitable for use as active pharmaceutical ingredients. The complex mixtures comprise at least a first major cannabinoid, at least a first minor cannabinoid, and optionally at least a first selected terpene. Also provided are methods of making the complex mixtures; pharmaceutical compositions comprising the complex mixture, and methods of using the pharmaceutical compositions for the treatment of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Lewy Body Dementia, or Huntington's disease.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: May 19, 2020
    Assignee: GBS GLOBAL BIOPHARMA, INC.
    Inventors: Andrea Small-Howard, Helen Turner
  • Patent number: 10653614
    Abstract: A cosmetic composition comprises a coffee cherry preparation, and most preferably an extract from a sub-ripe quick-dried coffee cherry. Particularly contemplated cosmetic compositions are formulated as a shampoo, lotion, cream, balm, or ointment, and will have at least one of an antioxidant effect, an anti-inflammatory effect, a UV-protective effect, an antimutagenic effect, a chemoprotective effect, a scar reducing effect, a skin-lightening effect, a moisturizing effect, a wrinkle reduction effect, and an antibacterial effect.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: May 19, 2020
    Assignee: VDF Futureceuticals, Inc.
    Inventor: Dusan Miljkovic
  • Patent number: 10653734
    Abstract: The document provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis. The document also provides methods for reducing pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: May 19, 2020
    Assignee: Melaleuca, Inc.
    Inventors: Alexander B. Rabovsky, Jeremy Ivie, Stephanie Nielson
  • Patent number: 10646534
    Abstract: The present invention belongs to the field of Chinese herbal medicine products, and more particularly relates to a formulation, preparation method and use of a Chinese herbal medicine composition for soothing the liver. The present invention provides a Chinese herbal medicine composition for soothing the liver, wherein the raw materials of the composition comprise Rhizoma Cyperi, Radix Angelicae Sinensis, Rhizoma Ligustici Chuanxiong, Radix Paeoniae Alba, and Pericarpium Citri Reticulatae. The present invention further provides a preparation method of the composition, comprising: step 1, extracting; step 2, concentrating; and Step 3, drying. Moreover, the present invention provides the use of the composition and the product obtained by the method in the treatment of a breast disease and/or remission of depression.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: May 12, 2020
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Shuo Liu, Huawei Zhu, Yiting Yang, Chung Wah Ma
  • Patent number: 10647668
    Abstract: A method for treating phytophotodermatitis including the steps of applying an isothiocyanate functional surfactant to an area affected by phytophotodermatitis, wherein said isothiocyanate functional surfactant comprises at least one isothiocyanate functional group associated with an aliphatic and/or aromatic carbon atom of the isothiocyanate functional surfactant.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: May 12, 2020
    Assignee: The William M. Yarbrough Foundation
    Inventor: Michael E. Silver
  • Patent number: 10646526
    Abstract: The present invention provides methods of extracting Cannabis plant material through use of aloe, compositions comprising the resulting Cannabis aloe extracts, methods of using the extracts to ameliorate skin conditions, and applicators for applying the extracts topically.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: May 12, 2020
    Assignee: ST&T INTERNATIONAL, INC.
    Inventor: Michael Scott
  • Patent number: 10639339
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: May 5, 2020
    Assignee: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Patent number: 10632164
    Abstract: Films that are mucosally dissolvable, and containing a matrix and one or more active agents from hemp or cannabis within the matrix, are provided. The disclosure also provides methods for preparing such a film for pharmaceutical and nutraceutical applications.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: April 28, 2020
    Inventor: Scott Schaneville
  • Patent number: 10632165
    Abstract: A composition comprising a therapeutically effective amount of Bidens pilosa extract, or an active compound isolated from the Bidens pilosa extract for use in treating obesity, reducing body weight or body weight gain, and/or gaining muscle mass or muscle content in a subject in need thereof is disclosed. The composition is useful for reducing fat cell size and/or fat accumulation in the fat cell in a subject in need thereof. The composition may further comprises an animal feed. A polyacetylenic compound for use in treating obesity, gaining muscle mass or muscle content, and/or increasing lean tissue protein content in a subject in need thereof is also disclosed. In one embodiment, the polyacetylenic compound is cytopiloyne.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: April 28, 2020
    Assignees: Academia Sinica, NATIONAL CHUNG HSING UNIVERSITY
    Inventors: Wen-Chin Yang, Lee-Tian Chang, Yu-Chuan Liang
  • Patent number: 10631556
    Abstract: A method for producing powderized cannabis oil, and the resulting powderized cannabis oil, in which concentrated cannabis oil is mixed with and absorbed by a modified starch powder, preferably maltodextrin, in a ratio of at least three grams of starch powder for every one-eighth of a gram of cannabis oil is disclosed. Further disclosed are beverages, baked goods and single-serve beverage brewing cartridges utilizing or incorporating the powderized cannabis oil to create human-consumable products that contain an emulsified, tasteless, and odorless dose of cannabis oil.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: April 28, 2020
    Assignee: PIVOT PHARMACEUTICALS US INC.
    Inventors: Ross M. Franklin, Ed Rosenthal, Rachel M. Franklin
  • Patent number: 10624872
    Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plant hemp extract. Products and supplements related to the method are also described.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: April 21, 2020
    Assignee: Charlotte's Web, Inc.
    Inventors: Alexander Michael McCorkle, Graham Taylor Carlson, Shelby Renee Sheahan
  • Patent number: 10624940
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: April 21, 2020
    Assignee: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Patent number: 10624844
    Abstract: A method of making cannabis oil hydrophilic comprising the steps of heating a base oil in the range of about 120 to 220° F., adding cannabis oil to create a mixture, blending the mixture at a high speed and adding at least one emulsifying agent to the mixture while blending, and adding water to form the composition wherein the cannabis oil is hydrophilic and is soluble in water.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: April 21, 2020
    Assignee: SRE Wellness, Inc.
    Inventor: Ronald Silver
  • Patent number: 10625176
    Abstract: This invention describes a method to extract and separate compounds from plant or animal material in a continuous process. The method uses dimethyl ether as a safe and efficient solvent which will extract polar and non-polar compounds. The extracted compounds are separated by distillation which is configured to provide individual compounds or groups of compounds.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: April 21, 2020
    Inventors: Larry Jack Melnichuk, Karen Sue Kelly
  • Patent number: 10625177
    Abstract: The present invention provides a step-by-step process for transforming the raw cannabis plant into an infused and bioavailable cannabis-plant-blend that can be used as a stand-alone food supplement; and can be integrated into tobacco replacement products, edible food products, or infused beverages of any kind. This unique and novel process includes multiple decarboxylation steps and produces a bioavailable cannabis product, which is inclusive of an infused amalgam of either: both heat-cooked and raw cannabis, or just heat-cooked cannabis; along with an infused blend of various chemical compounds.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: April 21, 2020
    Inventor: David Harold Moore
  • Patent number: 10624936
    Abstract: A method of reducing stress and anxiety in an equine comprising administering a therapeutically effective amount of a water-based cannabinoid formulation is provided, where the formulation contains no tetrahydrocannabinol. While many cannabinoids are suitable, the formulation may contain pure cannabidiol as the primary or only cannabinoid.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: April 21, 2020
    Inventors: Cynthia Denapoli, Albert Denapoli
  • Patent number: 10624868
    Abstract: A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: April 21, 2020
    Assignee: GLYKON TECHNOLOGIES GROUP, LLC
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre, Brad J. Douglass
  • Patent number: 10624941
    Abstract: A method for increasing expression of NOS3 gene, increasing expression of PLAT gene, decreasing expression of F3 gene and/or decreasing expression of SERPINE1 gene is provided, wherein the method comprises administering to a subject in need an effective amount of a Chenopodium formosanum extract. Accordingly, the method is effective in treating or preventing diseases associated with NOS3 gene, PLAT gene, F3 gene and/or SERPINE1 gene.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: April 21, 2020
    Assignee: TCO Co., Ltd.
    Inventors: Yung-Hsiang Lin, I-Hui Chen, Yu-Ting Cheng
  • Patent number: 10617636
    Abstract: A cannabis infused sweetener comprising cannabis oil; at least one emulsifying agent selected from the group consisting of xanthan gum, guar gum, lecithin, carrageen, monoglycerides, natural emulsifiers and organic emulsifiers that are safe for ingestion by humans; and a sweetener; and a cannabis infused elixir comprising cannabis oil; at least one emulsifying agent; a sweetener and flavoring extracts or fruit syrups; both the sweeteners and the elixirs are bio-available, fast acting and highly metabolizable.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: April 14, 2020
    Assignee: SRE Wellness, Inc.
    Inventor: Ronald Silver
  • Patent number: 10610465
    Abstract: Disclosed is an apparatus and methods for its use that is configured to be used to treat various skin conditions. The apparatus includes a water-permeable absorbent material and a plant material comprising a water-soluble skin-active ingredient. The plant material is enclosed within the water-permeable absorbent material, and the water-permeable absorbent material is configured to absorb water and allow the absorbed water to contact the plant material so as to release the active ingredient from the plant material. The active ingredient is then absorbed by the absorbent material, which is then topically applied to skin in need of skin treatment.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: April 7, 2020
    Assignee: Mary Kay Inc.
    Inventors: Daniel Chen, James Swanzy
  • Patent number: 10610560
    Abstract: The present invention is directed to a therapeutic method of independent or adjuvant treatment of Parkinson's disease and Parkinson's syndrome, comprising administering to a subject in need a therapeutically effective amount of Chinese medicine composition, wherein the Chinese medicine composition comprises the extract of the mixture of Rhizoma Pinelliae, Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae, Rhizoma Atractylodis, Rhizoma Alismatis, Pericarpium Citri Reticulatae, Massa Medicata Fermentata, Fructus Hordei Germinatus, Rhizoma Zingiberis, Cortex Phellodendri, rhizoma Gastrodiae, Radix Aconiti Lateralis Praeparata, Radix Angelicae Sinensis, and Radix Astragali.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: April 7, 2020
    Inventor: Chen-Yu Lee
  • Patent number: 10610479
    Abstract: The present invention provides cosmetic formulations for improving the appearance of the skin, particularly the lips. The compositions of the invention provide multiple enhanced technologies that work synergistically to enhance hydration and appearance of the skin. Anti-aging peptides and tissue respiratory factor work together in an HA rich environment to enhance collagen and elastin while beneficial antioxidants protect HA in the lip from damaging exposure.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: April 7, 2020
    Assignee: Jan Marini Skin Research
    Inventors: Jan L. Marini, Subhash J. Saxena
  • Patent number: 10603301
    Abstract: The present invention discloses a pharmaceutical topical composition comprising cannabidiol (CBD) or a derivative thereof and Tetrahydrocannabinol (THC) or a derivative thereof in an about 1:1 ratio, useful for treatment or prevention of inflammatory skin disorders, and treatment methods thereof.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: March 31, 2020
    Assignee: One World Cannabis LTD
    Inventors: Alon Sinai, Ziv Turner, Yehuda Baruch
  • Patent number: 10603344
    Abstract: The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of Cannabis sativa subsp. sativa for the treatment of disease. The invention further relates to the production of the extract and pharmaceutical compositions comprising said extract and the uses thereof.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: March 31, 2020
    Assignee: Canopy Growth Corporation
    Inventors: Heinz Letzel, Regina Klaeger, Rudolph Klaeger
  • Patent number: 10596211
    Abstract: A method for delivering therapeutics includes infusing botox with cannabis.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: March 24, 2020
    Inventor: Shabana Naheed
  • Patent number: 10596216
    Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: March 24, 2020
    Assignee: Ethnodyne and Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouazzani, Guillaume Arcile
  • Patent number: 10596147
    Abstract: Compositions, systems, and methods that can be used with a pressurized metered dose inhaler are disclosed. A pharmaceutical composition for use in a pressurized metered dose inhaler can comprise a cannabinoid composition, a co-solvent, a terpene composition, and a propellant. A pharmaceutical composition may be soluble. A system can comprise a plurality of cannabinoid compositions and/or a plurality of terpene compositions available in various combinations. One of a plurality of cannabinoid compositions and terpene composition combinations may be user-selectable in response to various factors such as a desired therapeutic benefit, sedative effect, flavor profile, or a combination of the foregoing. A method of formulating a soluble pMDI pharmaceutical composition comprising a cannabinoid composition, a co-solvent, a terpene composition, and a propellant is disclosed.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: March 24, 2020
    Assignee: Vapen, LLC
    Inventor: Jason Ty Nguyen
  • Patent number: 10596148
    Abstract: The present invention provides safe and effective topical compositions for the treatment of psoriasis and alleviation and prevention of frequent recurrence of psoriasis symptoms as well as treatment of seborrheic dermatitis. The compositions comprise therapeutically effective amounts of salicylic acid, zinc oxide, bisabolol, at least one pharmaceutically acceptable carrier selected from the group comprising white petrolatum, lanolin, propylene glycol, and combinations thereof, herbal oils selected from the group comprising Salvia Hispanica seed oil, evening primrose oil, grape seed oil, Nigella seed oil, Silybum Marianum oil, Primus Amygdalus Dulcis (sweet almond) oil, borage oil, Lavendula Angustifolia (lavender) oil, Cannabis sativa seed oil and mixtures thereof and other pharmaceutically acceptable ingredients. Unlike many topical compositions for the treatment of these skin afflictions, the compositions of the instant invention do not contain steroids (like cortisone) or coal tar.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: March 24, 2020
    Assignee: Prestigio Ltd.
    Inventors: David Merary, Iris Raveh
  • Patent number: 10588928
    Abstract: An anti-obesity composition comprises pine needle juice powder as an effective component. Because it is found that, not only a significantly higher extraction yield is obtained and a higher inhibitory activity on differentiation of an adipocyte is obtained when an extract is produced by using pine needle juice powder obtained by juicing process instead of using dry pine needle which has not been treated with any juicing process, but also both the body weight and weight of white adipose tissues are lowered and content of total lipid, total cholesterol, and triglyceride in blood is significantly lowered according to oral administration of the pine needle juice powder of the present invention to a model mouse under high fat diet, the pine needle juice powder of the present invention can be more advantageously used for a pharmaceutical composition or a functional health food for prophylaxis or treatment of obesity.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: March 17, 2020
    Inventors: Hyeonsook Cheong, Woong Kim, Jaeyoung Park, Beomgi Lee, Cheolwoo Park
  • Patent number: 10583160
    Abstract: A purified lipid-based solution including cannabinoids is manufactured by providing a lipid solution including an array of triglycerides, cannabinoids and water soluble contaminants. Adding water to the lipid solution to create a mixture and heating the mixture in a pressure vessel to a temperature above the melting point of the lipid solution. The mixture is agitated to dissolve the water soluble contaminants and electrocoagulated. The mixture is cooled to cause the triglycerides and cannabinoids to solidify. The water is separated from the mixture to remove water soluble contaminants, precipitated contaminants, suspended solids and colloids from the mixture to yield a purified lipid solution.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: March 10, 2020
    Assignee: Raderman Holdings LLC
    Inventor: Joshua Michael Raderman
  • Patent number: 10576048
    Abstract: Compositions and methods for treating skin redness. According to an embodiment, the invention is a topical skin care composition having a dermatologically acceptable vehicle, such as, water and a plurality of ingredients dissolved in the vehicle. The ingredients include: a blend of natural oils; a plurality of vitamins; and 0.1-1 wt % salicyloyl phytosphingosine. The composition is unsuitable for application on the eyelids or eye area. The blend of natural oils includes: aloe barbadensis leaf juice extract; cocos nucifera (coconut oil); hydrolyzed glycosaminoglycans; and caprylic/capric triglycerides. The plurality of vitamins is selected from a group consisting of vitamin C, vitamin E, salts/derivatives of vitamin C and vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins includes: sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: March 3, 2020
    Assignee: OCuSOFT, Inc.
    Inventors: Nat Adkins, Jr., Troy Smith
  • Patent number: 10576116
    Abstract: The present invention relates to extracts derived from plants and/or fractions thereof, compositions comprising same and use thereof in protecting tissues from damages caused by exogenous toxins. In particular, the present invention relates to polar extract and/or fraction thereof derived from Asteriscus graveolens, compositions comprising same and use thereof in protecting tissues comprising epithelial cell from the deleterious effect of exogenous toxins, particularly toxins originating from environmental pollution.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: March 3, 2020
    Assignee: I.B.R. Israeli Biotechnology Research Ltd.
    Inventors: Ofir Ramot, Fabien Havas, Eyal Kalo, Liki Von Oppen-Bezalel, Raffi Arnon, Olga Ben-Chitrit, Inon Perry
  • Patent number: 10568864
    Abstract: A process is disclosed for extracting cannabinoids from plant materials. The process comprises providing a pressurizable extraction vessel having a rotatable drum with baffles, along with providing a solvent permeable filter bag. The plant material is placed within the filter bag, and the filter bag containing the plant material is placed within the extraction vessel. The extraction vessel is then filled with subcritical liquid carbon dioxide and rotated to so that the plant material is in contact with the liquid carbon dioxide. After a selected period of time, the liquid carbon dioxide solvent containing the cannabinoid extracted from the plant material is removed from the vessel, and sent to a separator. The separator separates the cannabinoid from the liquid carbon dioxide solvent.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: February 25, 2020
    Assignee: Cool Clean Technologies, LLC
    Inventors: Nelson W. Sorbo, Jon R. Turner, Jon Wikstrom
  • Patent number: 10569194
    Abstract: The present disclosure relates to luterion, which is a mitochondrial-like micro-material, and separating and culturing methods for same and, more particularly, to a method for separating luterion by means of a filter having a pore of a particular size, luterion which is separated by means of the method thereof and has unique properties, and a culturing method for proliferation of the luterion.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: February 25, 2020
    Assignee: LUTERION CO., LTD.
    Inventors: Young Ah Kwon, Won Cheol Choi, Suk Hoon Choi, Chang Hoon Choi
  • Patent number: 10568922
    Abstract: The present invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to the present invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: February 25, 2020
    Assignee: JAEIN RESEARCH AND PHARMACY
    Inventors: Seong Gyu Ko, Sung Gook Cho, Youn Kyoung Choi, Hee Sun Yim